Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
KRASG12C Mutation
.
Show all posts
Showing posts with label
KRASG12C Mutation
.
Show all posts
Thursday, January 19, 2023
FDA Approves Krazati (adagrasib) for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
›
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a targeted oncology company, announced the U.S. Food and Drug Administration (FDA) approval of ...
›
Home
View web version
